• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of OE-recommended and posted health fraud internet site warning letters

Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.

Information is current as of February 12, 2013.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber of recommended WLs
Oct 2012N/A3
Nov 2012N/A3
Dec 2012N/A2
Jan 2013N/ATBD
Feb 2013N/ATBD
Mar 2013N/ATBD
Apr 2013N/ATBD
May 2013N/ATBD
Jun 2013N/ATBD
Jul 2013N/ATBD
Aug 2013N/ATBD
Sep 2013N/ATBD

Percent of OE-recommended health fraud internet site warning letters approved by the Center for issuance and posting on FDA.gov

Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 2012N/A0
Nov 2012N/A67
Dec 2012N/A0
Jan 2013N/ATBD
Feb 2013N/ATBD
Mar 2013N/ATBD
Apr 2013N/ATBD
May 2013N/ATBD
Jun 2013N/ATBD
Jul 2013N/ATBD
Aug 2013N/ATBD
Sep 2013N/ATBD

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.